Heart disease is the leading cause of death for Americans. Kaiser Permanente Washington Health Research Institute (KPWHRI) scientists are working to understand how to reduce our risk of heart attacks, stroke, and other cardiovascular diseases throughout life.
Addressing risk factors, improving diagnosis, and exploring how medications, genes, and everyday life affect our cardiovascular health at different ages and stages are central to this work — as is translating research findings into practical, personalized care.
“We’ve found that helping patients and health care teams work together on personalized care plans is the best path to lifelong heart health,” says Beverly Green, MD, MPH, whose recent work has focused on improving the diagnosis of high blood pressure.
Additional focus areas for KPWHRI scientists include exploring the impact of cardiovascular diseases on other health conditions — and vice versa. Recently, this has led researchers Sascha Dublin, MD, PhD, and Laura B. Harrington, PhD, MPH, to investigate the impact of COVID-19 on cardiovascular health.
Below are other research highlights from KPWHRI’s cardiovascular health scientists (please visit their bios to learn more):
Sivarajan ES, Newton KM. Exercise, education, and counseling for patients with coronary artery disease. Clin Sports Med. 1984;3(2):349-69. PubMed
Walker AM, Jick H, Hunter JR, McEvoy J. Vasectomy and nonfatal myocardial infarction: continued observation indicates no elevation of risk. J Urol. 1983;130(5):936-7. PubMed
Sivarajan ES, Newton KM, Almes MJ, Kempf TM, Mansfield LW, Bruce RA. Limited effects of outpatient teaching and counseling after myocardial infarction: a controlled study. Heart Lung. 1983;12(1):65-73. PubMed
Ott CR, Sivarajan ES, Newton KM, Almes MJ, Bruce RA, Bergner M, Gilson BS. A controlled randomized study of early cardiac rehabilitation: the Sickness Impact Profile as an assessment tool. Heart Lung. 1983;12(2):162-70. PubMed
Smith NL, Heit JA, Tang W, Teichert M, Chasman DI, Morange PE; on behalf of the Venous Thrombosis Genetic Replication Consortium. Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of 8 studies. J Thromb Haemost. 2012 Apr;10(4):719-22. doi: 10.1111/j.1538-7836.2012.04665.x. PubMed
![]() Sascha Dublin, MD, PhDSenior Investigator |
![]() Beverly B. Green, MD, MPHSenior Investigator |
![]() Laura Harrington, PhD, MPHAssociate Investigator |
![]() Ellen O'Meara, PhDPrincipal Collaborative Scientist |
![]() Nicole M. Gatto, PhD, MPHPrincipal Collaborative Scientist |
![]() Meagan C. Brown, PhD, MPHAssistant Investigator |
James Floyd, MD, MS
Assistant Professor, Department of Medicine
Adjunct Assistant Professor, Department of Epidemiology
University of Washington
Susan Heckbert, MD, PhD
University of Washington (UW) Department of Epidemiology; UW Cardiovascular Health Research Unit
Nicholas L. Smith, PhD, MPH
UW Professor, Epidemiology, Cardiovascular Health Research Unit
Director, Seattle Epidemiology and Information Resource Center, VA Puget Sound Health Care System